Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity
- PMID: 3540828
- DOI: 10.1203/00006450-198612000-00014
Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity
Abstract
Experiments performed in vitro have demonstrated that leukocyte neutral proteases produce an important mediator of inflammation, C5a, by proteolysis of the C5 component of the complement system. Cystic fibrosis (CF) lung fluids were characterized by high levels of neutrophils (39% of total cells versus 2% in normals) and contained significantly elevated amounts of elastolytic activity (mean 17.7 ng/micrograms total protein) compared to the lung fluids obtained from normal volunteers (0.2 ng elastolytic activity/micrograms protein, p = 0.001). The objective of these studies was to determine if complement activation and complement-derived chemotactic activity are present in CF lung fluids. C3c peptide representing activation of C3 could not be identified in the bronchial-alveolar lung lavage fluids of normal subjects but was readily identified by means of crossed immunoelectrophoresis in CF lung fluids (n = 9, mean 49% of C3); the mean level of C3 was decreased in CF lung specimens. Chemotactic activity was significantly elevated in lung fluids of the CF patients when compared to normal lung fluids. Using gel-filtration chromatography and a sensitive radioimmunoassay the chemotaxin present in CF specimens was identified as the anaphylatoxin C5a. C5a levels in the bronchial-alveolar lavage fluids of CF patients was inversely related to volume in liters expired in 1 s of a forced expiratory maneuver expressed as a percent of vital capacity determined from a forced expiratory maneuver (r = -0.72). Because there was a direct relationship between the total elastolytic activity present in CF airways and the concentration of C5a (r = 0.97, p = 0.03), it was postulated that airway proteases with elastolytic activity also cleave C5, nonimmunologically producing C5a. Detailed inhibition assays revealed that much of the total elastolytic activity had the inhibition profile of a serine proteinase. The levels of the serine proteinases were closely correlated with the numbers of neutrophilic leukocytes present per ml of lavage fluid (r = 0.7, p = 0.05). However, inhibitors of leukocyte serine proteases did not prevent the generation of additional chemotactic activity and the proteolysis of radiolabeled C5 substrate was not prevented by inhibitors of neutrophil elastase. Although the purified metalloelastase of Pseudomonas aeruginosa was active on cell-bound and free C5 yielding C5a, inhibition of this bacterial protease in CF lung fluids only partially blocked cleavage of the alpha- and beta-chains of C5.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.J Clin Invest. 1984 Jul;74(1):236-48. doi: 10.1172/JCI111407. J Clin Invest. 1984. PMID: 6429195 Free PMC article.
-
Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.J Exp Pathol. 1984 Summer;1(3):201-16. J Exp Pathol. 1984. PMID: 6400640
-
Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.Am J Pathol. 1979 Jan;94(1):75-83. Am J Pathol. 1979. PMID: 569981 Free PMC article.
-
The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.Crit Rev Immunol. 1981 Feb;1(4):321-66. Crit Rev Immunol. 1981. PMID: 7037298 Review. No abstract available.
-
The role of bacterial proteases in the pathogenesis of cystic fibrosis.Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S118-22. doi: 10.1164/ajrccm/150.6_Pt_2.S118. Am J Respir Crit Care Med. 1994. PMID: 7952646 Review.
Cited by
-
Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.Infect Immun. 1994 Oct;62(10):4145-52. doi: 10.1128/iai.62.10.4145-4152.1994. Infect Immun. 1994. PMID: 7927669 Free PMC article.
-
Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line.Thorax. 2000 May;55(5):364-9. doi: 10.1136/thorax.55.5.364. Thorax. 2000. PMID: 10770816 Free PMC article.
-
Subversion of the Complement System by Pseudomonas aeruginosa.J Bacteriol. 2023 Aug 24;205(8):e0001823. doi: 10.1128/jb.00018-23. Epub 2023 Jul 12. J Bacteriol. 2023. PMID: 37436150 Free PMC article. Review.
-
Nitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells.Antimicrob Agents Chemother. 1999 Apr;43(4):794-801. doi: 10.1128/AAC.43.4.794. Antimicrob Agents Chemother. 1999. PMID: 10103183 Free PMC article.
-
Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.Arch Dis Child Fetal Neonatal Ed. 1996 Jan;74(1):F51-5. doi: 10.1136/fn.74.1.f51. Arch Dis Child Fetal Neonatal Ed. 1996. PMID: 8653437 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous